BioLargo reports Q2 2026 results; revenue up 12%
BioLargo (BLGO) reports second-quarter 2026 results with revenue up 12% sequentially and gross margin expanding to 54%.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.